Long-acting conjugate of triple glucagon/GLP-1/GIP receptor agonist
US10400020B2 · kind B2 · utility
6Cited by
6References
24Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 29, 2018 |
| Grant date | Sep 3, 2019 |
| Priority date | — |
| Expiry date | Jun 29, 2038 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P9/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a long-acting conjugate of a triple agonist having activities to all of glucagon, GLP-1, and GIP receptors and uses thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.